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Abstract: Allergist/clinical immunologist maintenance of certiﬁca-
tion and training program reaccreditation are mandatory in some
countries. The World Allergy Organization conducted surveys in
2009 and 2011 to assess where such programs were available and to
promote the establishment of such programs on a global level. This
was done with the presumption that after such an “inventory,” World
Allergy Organization could offer guidance to its Member Societies
on the promotion of such programs to assure the highest standards of
practice in the ﬁeld of allergy and clinical immunology. This review
draws on the experience of countries where successful programs are
in place and makes recommendations for those wishing to implement
such programs for the specialty.
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Medical science and the practice of medicine are contin-uously evolving at an ever-increasing rate. The public
expects the medical profession to deliver the highest quality of
care to patients. Development and maintenance of professional
standards through maintenance of certiﬁcation (MOC) is one
method to do so. This is a self-sustaining process promoted by
different entities in various parts of the world. The purpose of
MOC is to make sure that the physicians adhere to updated
standards in the specialty and to ensure cost-effectiveness in
their practice. In addition, the same process indirectly inﬂu-
ences and discourages unacceptable medical practices.1 Med-
ical specialty certiﬁcation, in the ﬁeld of allergy/immunology,
begins the process of assuring quality medical care.2,3 Beyond
initial certiﬁcation, MOC is mandatory to guarantee that the
process of learning and staying current with medical advance-
ments is a lifelong process.4,5 Six core competencies are
identiﬁed by the American Board of Medical Specialties to
be important in the process. They include patient care, pro-
fessionalism, practice improvement, medical knowledge,
communications, and systems-based practice.6
The World Allergy Organization (WAO) is an in-
ternational umbrella organization whose members consist of
89 regional and national allergy and clinical immunology
societies from around the world. By collaborating with
its member societies, WAO provides direct educational
outreach programs, symposia, and lectures to members in
100 countries.7 The WAO Board of Directors initiated this
project to make an inventory of MOC practices in the
national member society countries. In 2009 and 2011, a sur-
vey was conducted among the members of the Education
Council, the Specialty and Training Council, and other
WAO bodies having rapport with the existing national sys-
tems for the MOC and for accreditation and reaccreditation of
training programs and schemes. The aim of the survey was to
ascertain whether such programs were well established at
a global level, or if there is a need for WAO to offer guidance
to its membership on the introduction and maintenance of
programs to promote high standards in the practice of allergy
and clinical immunology. The responses received from dif-
ferent geographical regions suggested that although some
countries had systems in place to conduct one or both of
these processes in the ﬁeld of allergy and clinical immunol-
ogy (Table 1), the global coverage was far from universal.
This review draws on the experience of countries where suc-
cessful systems are in place to make recommendations for
those wishing to implement a national system for allergy and
clinical immunology specialists.
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TABLE 1. MOC/Accreditation of training programs
Country/Region Original Certiﬁcation Agency MOC Requirements
Accreditation of Training Programs and
Accrediting Bodies
North America
USA American Board of Medical
Specialties through American
Board of Allergy and Immunology
certiﬁcation examination (http://
www.abms.org)
MOC examination and modules 10
year cycle requiring a certain
number of modules; take home test
every 5 years
Yes: http://www.abms.org/; American Board
of Medical Specialties: http://www.abms.
org/Maintenance_of_Certiﬁcation/
Mexico Mexican Board of Certiﬁcation in








Australia Royal Australasian College of
Physicians
Five year recertiﬁcation cycle Yes; Royal Australasian College of
Physicians, Joint Scientiﬁc Advisory
Council
Korea Internal Medicine and Pediatric
Societies
Recertiﬁcation every 5 years Yes; cContact: bwcho@cau.ac.kr or
Kaim4364@kams.or.kr
Japan JSA: info@jsaweb.jp; JSA Web site
at http://www.jsaweb.jp/index.html
No recertiﬁcation system Yes; all universities and hospitals that have
JSA certiﬁed allergists
Europe
Czech Republic Institute for Postgraduate Education
in Medicine (Certiﬁcation Board
for Allergy and Clinical
Immunology) and Universities
No recertiﬁcation system;CME Yes; programs are approved by the
Accreditation Council for Allergy and
Clinical Immunology of Czech Ministry of
Health
Germany German Medical Association sets up
content and duration of training;
Certiﬁcation is done by the
respective Chamber of Physicians
(per county), oral test, etc
Chamber of Physicians establish local
criteria
Yes; 250 credit points in 5 years; however,
these points may also be acquired in
different related specialties (eg,
dermatology, otorhinolaryngology, etc)
Italy University gives to the Specialty the
legal value on behalf of the
government
No, but CME is required Yes; the programs of the training are the
same for the Specialty Schools
Switzerland Federatio Medicorum Helveticorum No recertiﬁcation; continuous CME
required
Yes; the Swiss Society of Allergology and
Immunology offers yearly courses and
certiﬁcates, which are voluntary; they are
attended by 70%–80% of all certiﬁed
allergologists
United Kingdom PMETB and the JRCPTB, now
merged with the General Medical
Council
No set recertiﬁcation requirements;
CME credits being considered as
revalidation
Yes; PMETB and the JRCPTB merged with
GMC. These committees look after the
Specialist Register.
Latin America
Argentina A Certiﬁcation Agency may be
a Hospital Residency/Postgraduate
Course either at the University, an
Allergy Association, or a Regional
Medical College
Recertiﬁcation every 5 years. by (1)
proof of minimum number of CME
credits or (2) written test
No uniform policy
Venezuela University/Hospital None No
Africa
South Africa HPCSA CME: 30 hours every 2 years Yes; CME compulsory for all Specialists and
general practitioners to continue practice;
this is randomly audited by the HPCSA;
no speciﬁc credits enforced for
Allergology, yet as specialty still being
gazetted (2011)
HPCSA, Health Professions Council of South Africa; JSA, Japanese Society of Allergology; JRCPTB, Joint Royal Colleges of Physicians Training Board; PMETB, Postgraduate
Medical and Education Training Board.
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A system to ensure continuous professional develop-
ment (CPD) of medical specialists requires 2 complementary
components:
1. A deﬁned process for MOC for specialists. This
includes speciﬁc procedures, goals, and time intervals.
2. Approved training programs to cover key specialist
competencies and their continuous upgrading and reva-
lidationdaccreditation and reaccreditation of training
programs.
The WAO Position Paper, “Requirements for physician
competencies in allergy: key clinical competencies appropri-
ate for the care of patients with allergic or immunologic dis-
eases,”8 outlined the optimal level of knowledge, technical
and skills objectives, and desirable attitudes for the allergy/
clinical immunology specialist. Depending on the local needs
and circumstances, such lists may provide a useful foundation
for the development of MOC and training program reaccre-
ditation in the ﬁeld of allergy and clinical immunology (see
Appendix). Training programs presently in use, in countries
where such procedures are mandatory, could also provide
useful models for countries where such programs do not exist.
The 2 components, MOC of individuals and reaccredi-
tation of training programs, should derive from and comple-
ment the continuous process of graduate and postgraduate
education. They should provide a vehicle to achieve smooth
transition to maturity of medical specialists and thus ensure
the growth of manpower resources in allergy and clinical
immunology. Their structure and function at a national level
may differ depending on the relationships between the
specialist community, academia, and the physician-licensing
authorities (Table 2).
FRAMEWORK FOR MOC/REACCREDITATION OF
TRAINING PROGRAM MODELS
The MOC/reaccreditation of training program models in
allergy and clinical immunology should take into account the
speciﬁc features of allergic diseases, recognizing that these are
systemic diseases with underlying immunological mechanisms
and with a wide variety of organ manifestations.9,10 They need
to address the wide-ranging skills, knowledge, and competen-
cies required for a specialist (ie, the allergist/clinical immunol-
ogist). However, there are conceptual differences between
MOC of specialists and accreditation/reaccreditation of train-
ing programs, which necessitate separate assessment programs
for each of these 2 entities. Ideally, the MOC or recertiﬁcation
of specialists should be based on the same standards of
achievement as the ones that regulate the ﬁrst time certiﬁca-
tion. Such standards should be decided by the leaders of the
specialty, or the corresponding government medical authori-
zation body (as in several countries, it is not the society that
gives the certiﬁcation but a medical council or relevant gov-
ernment authority in medicine), and the standards should be
periodically updated in line with the most current medical
literature and the needed care of the population served.
Although the ﬁrst time certiﬁcation is the starting point of
an independent specialist career and should therefore require
particular scrutiny on the part of a certiﬁcation authority, the
subsequent MOC time points should provide for evidence of
incorporation of novel diagnostic and treatment modalities
into an individual’s clinical practice. Therefore, the MOC pro-
cedures should make use of continuous medical education
(CME) and CPD systems for life-long learning at the regional
level, national level, and where available, international level.
The time points for MOC should reﬂect the evolution of new
information in the specialty. The process should not be puni-
tive. Typically, 3 or 4 MOC cycles would be appropriate for
a lifetime specialist career of 30 to 35 years. The oversight of
MOC of specialists preferably should be exercised by the pro-
fessional authority issuing the initial certiﬁcation and not by
the governmental institutions and agencies.
At a national level, the process of accreditation/
reaccreditation of training programs should involve the
participation of a broad circle of experts, specialty organ-
izations, and training program directors or their designees,
and it should be driven “on demand” by practice-changing
innovations. Such programs should be required to provide
evidence of graduating a certain number of students to spe-
cialist status over a given period (eg, a 5-year period) as
a measure of their effectiveness.
WAO can contribute to the establishment of globally
recognized standards in allergy and clinical immunology
practice in 2 ways. First, by establishing and regularly
updating the recommendations for physician training in
allergy and clinical immunology to provide the following:
1. A model of required and desirable specialist knowledge,
technical and skill objectives, and desirable attitudes for
TABLE 2. A Successful SystemdMOC in Australia
MOC and accreditation of training centers in Australia
Training, accreditation of training centers, and maintenance of standards (known as My CPD) is formulated and managed within the RACP
Training criteria and accreditation of training places is overseen by a Joint Scientiﬁc Advisory Council for each specialty. There are detailed criteria by which
to assess competence of trainees and also for the assessment of each training position. Supervisors have very detailed criteria to meet for each trainee and
must sign off that these have been met
Once specialty status is gained, the individual follows the RACP MOC process. This is run over 5-year cycles. It is a continuous annual process that is wholly
electronicdparticipants identify personal professional development needs, plan activities to meet those needs, and reﬂect on the activities undertaken as part
of an ongoing professional development cycle
The national professional societydthe Australasian Society for Clinical Immunology and Allergydis not involved in the process
RACP, Royal Australasian College of Physicians.
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the initial certiﬁcation and MOC of individuals, which will
in turn provide a benchmark for training program content
for accreditation/reaccreditation purposes (Appendix);
2. A self-assessment tool for allergists who are considering
their individual educational needs and CME require-
ments, for example, accreditation programs that involve
reading online lectures and updates and answering mul-
tiple choice questions and awarding “knowledge”
accreditation points, which local allergy training councils
will accept for the purposes of recertiﬁcation. In addition,
there could be recommended mechanisms of assessing
clinical competence and procedures by the local medical
councils/bodies.
Second, by recommending the global introduction of
MOC standards to help national societies provide a lobby for
a challenging, cost-effective, mostly nonpunitive educational
process and also to propose how it should be implemented.
The national societies of allergy and clinical immunology, and
training program directors or their designees, should be the
natural interface for the adoption of new practices for the
existing programs, and it should maintain a dialogue with
allergy/clinical immunology specialists and appropriate health
care organizations. This cross talk should allow both specialists
and institutions to have a say in incorporating their respective
needs into the training program accreditation/reaccreditation
process. At the same time, precautions should be in place to
prevent commercial bias and self-serving behavior.
Understandably, variations are expected between coun-
tries, depending upon the maturity of the specialty and whether
allergy and/or allergy/clinical immunology is recognized as
a separate specialty or a subspecialty. This fact probably
accounts for the poor rate of response to the WAO survey
because in countries where allergy/clinical immunology is not
recognized as a specialty, individuals refrained from answering
the questionnaire. This limitation could be overcome further
down the road by adding data through personal contacts and
telephone calls. Where allergy and/or allergy/clinical immu-
nology does not currently have specialty recognition, the
WAO recommendations for the competencies required to treat
patients with allergic and immunologic diseases may be
particularly helpful for the individual specialist seeking to
identify appropriate CPD and CME educational activities. This
review article should be a benchmark for societies and national
medical bodies around the globe to help them establish such
programs, setting up their own time frame for achieving it.
ADMINISTRATIVE AND LEGAL ASPECTS
The concept of MOC presumes the existence of
a recognized certifying authority. It would be advisable to
have a national administrative nongovernmental authority
responsible for enunciating the national standard and hosting
the process of certiﬁcation and MOC of allergy/clinical
immunology specialists and also for vetting the process at
regular intervals. The scientiﬁc content and logistic structure
and functions should be deﬁned by a legal document issued
by the governing institution or a legislative body.
The organization of the procedure for accreditation and
reaccreditation of training programs should be the joint task
of the national societies of allergy/clinical immunology and
the national training programs, or corresponding national
medical government bodies who are authorized to provide
such certiﬁcation. This procedure may be sanctioned by the
administrative body, under whose jurisdiction the certiﬁcation
and MOC of medical specialists occurs.
SUMMARY
Systems that support the need for allergists/clinical
immunologists to pursue lifelong education to maintain and
update their clinical competency and to ensure that training
programs are up-to-date and effective will lead to improved
patient care and enhance recognition of the specialty of
Allergy and Clinical Immunology.
For those countries wishing to implement such systems,
WAO offers the following recommendations for the in-
stitution and standardization of programs designed to ensure
the development and maintenance of skills and competencies
for the allergist/clinical immunologist:
1. The guiding factor in the development of a program is
that it will beneﬁt both patients and physicians
2. The program should be nonpunitive to the physician for
whom it is intended
3. The program should contain a didactic element; the pro-
cess to implement it should be a learning experience
ending in an examination, which demonstrates increased
medical knowledge
4. Multiple sources of information are necessary to demon-
strate the competency of the physician seeking MOC,
including patients, ancillary staff, fellow specialists, and
other physicians and health professionals. Multiple as-
sessment tools are necessary, including open-book testing
of knowledge, proctored examinations, practice assess-
ment, patient care outcomes, and quality improvement
5. The process should be ﬂexible and adaptable to changes
in medicine, science, and the practice of allergy and
clinical immunology, and it should recognize local
needs, availability of medications and diagnostic tests,
and service capabilities
6. Outcomes should be identiﬁed that can be monitored
and quantiﬁed to verify that the process is beneﬁcial
7. If problems appear in the MOC for individuals, or in the
procedures for revalidation of training programs, which
have the potential to jeopardize patient care or the edu-
cation of physicians, a remediation process to rectify the
problems and processes is necessary. If these problems
cannot be rectiﬁed, then the physician or the training pro-
gram in question should not be recertiﬁed/reaccredited.
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APPENDIX: Recommended Objectives for
Physician Competencies in Allergy
The following lists are taken from the “Requirements for
physician competencies in allergy: key clinical competencies
appropriate for the care of patients with allergic or immuno-
logic diseases.”8 Based on the local needs and service capa-
bilities, these recommendations may be divided as
appropriate into “recommended” and “desirable” objectives,
or omitted if inappropriate to the local situation.
A. Knowledge Objectives
1. Immune mechanisms involved in the development of
immunologically mediated diseases and, in particular,
allergic sensitization and disease formation.
2. Genetic and environmental factors, including infec-
tious diseases, involved in the genesis of allergic
diseases.
3. Pathogenesis of rhinoconjunctivitis, otitis, rhinosinusi-
tis, asthma, atopic dermatitis, urticaria, and angioe-
dema; drug and food allergy; insect allergy and
anaphylaxis; and the concept that most allergic dis-
eases are systemic in etiology.
4. Relationship between tissue inﬂammation and repair.
5. Mechanisms of IgE-mediated immediate phase and
late or delayed phase allergic reactions.
6. Mechanisms of non-IgE-mediated allergic reactions and
other disorders in the differential diagnosis of allergic
disease: These diseases include, but are not limited to,
nonallergic rhinitis, drug-induced rhinitis, acute and
chronic rhinosinusitis, nonallergic asthma, cough, bron-
chitis, non-IgE-mediated anaphylaxis, idiopathic urti-
caria, eczema, otitis, conjunctivitis, eosinophilic
esophagitis, gastroenteritis, and colitis, celiac-like syn-
dromes, food-induced enteropathies leading to gastro-
esophageal reﬂux, esophagitis, gastritis, and gut
motility disorders, including constipation.
7. National, regional, and global epidemiology of allergic
diseases.
8. Local airborne, contact, and occupational allergens.
9. Classiﬁcation and relative importance of all relevant
allergens and their biological characteristics, including
heat and digestive stability and cross-reactivity, under-
standing of local pollen counts and the characteristics of
various aeroallergens and routes of allergen exposure.
10. Therapy
(a) Use and route of administration of antihistamines;
mast cell stabilizers; bronchodilators; nasal, oral, and
parenterel, topical, and inhaled glucocorticosteroids;
decongestants; leukotriene modiﬁers; theophylline; adren-
ergic agonists; anticholinergics; mucolytics; antibiotics;
adrenaline; and all other pharmacologic and immunologic
agents used to treat allergic and immunologic diseases.
(b) Use of emollients, antibiotics, topical glucocorticos-
teroids, immune modulators, and all other agents and
techniques used to manage eczema and other allergic
skin disorders.
(c) Use of immune modulators, such as speciﬁc aller-
gen immunotherapy, monoclonal antibodies, including
anti-IgE, and immunoglobulin replacement used to
treat allergic and immunologic disorders, knowledge
of immune modulators that are being developed for
clinical use in allergic and immunologic disorders.
(d) Methods and value of allergen-avoidance techniques.
(e) Avoidance diets and nutritional implications of dietary
modiﬁcation.
(f) Knowledge of national and international guidelines
for the management of anaphylaxis, allergic and immu-
nologic disorders in adults and children, with particular
emphasis on safety and efﬁcacy of all therapies.
11. Investigation and management of adverse reactions to
drugs and vaccines.
12. Methods to measure cells and mediators in biological
ﬂuids and tissues.
13. Primary and secondary prevention of allergy, particu-
larly in children.
14. Understanding of the social and psychological issues
associated with allergic diseases.
15. Diagnosis and management of occupational allergic
diseases.
16. Methods to monitor home or work environments for
allergens associated with allergic diseases.
17. Understanding of environmental factors such as pollu-
tants and occupational allergens and of viral
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respiratory tract infections that affect allergic sensitiza-
tion and disease development.
18. Recognition/diagnosis and treatment or appropriate refer-
ral of patients with humoral and cellular immunodeﬁcien-
cies, hereditary and acquired complement deﬁciencies,
and phagocytic disorders, depending upon whether the
specialist is an allergist or allergist/clinical immunologist.
B. Skills Objectives
1. Clinical skills
Differential diagnosis, evaluation, and management or






Asthma, cough, dyspnea, and recurrent wheeze
Acute and chronic urticaria, including physical urticarias
Angioedema, including hereditary angioedema
Anaphylaxis
Food allergy and intolerance




Occupational allergy, asthma, eczema
Otitis





Abnormalities of phagocytic cells
Management of patients with multiple or complex
allergies and eosinophilic disorders.
2. Management of patients with multiple food allergies,
requiring avoidance diets.
3. Provision of allergen avoidance advice.
4. Safe supervision of food and drug challenges.
5. Assessment of patients for immunotherapy. Proper
administration of immunotherapy including immuno-
therapy dose adjustment and management of compli-
cations. Supervision of immunotherapy protocols.
Recognition and management of allergic reactions
associated with immunotherapy.
6. Recognition of indications for and the skills to per-
form, interpret, and understand the limitations of skin
prick, intradermal, patch, and delayed type skin tests,
and speciﬁc in vitro IgE antibody tests.
7. Interpretation of natural allergen and environmental
exposures.
8. Evaluation and differentiation of non-IgE-mediated
hypersensitivity reactions.
9. Investigation and management of behavioral problems
related to allergic and immunologic diseases.
10. Improvement of patient compliance with pharmaco-
therapy regimens through personalized disease man-
agement plans.
11. Management in the community of patients at risk of
anaphylactic reactions, incorporating an understanding
of integrated care pathways.
12. Diagnosis, treatment, and/or referral of primary and sec-
ondary humoral and cellular immunodeﬁciencies. Such
diseases include, but are not limited to, X-linked agam-
maglobulinemia, common variable immunodeﬁciency,
functional antibody deﬁciency, severe combined immu-
nodeﬁciency, thymic dysplasia, Wiskott–Aldrich syn-
drome, ataxia telangiectasia, and various lymphocyte
activation defects.
13. Safe and effective administration of intravenous and
subcutaneous gamma globulin.
14. Recognition and management or appropriate referral of
hereditary and acquired complement deﬁciencies.
15. Knowledge about and treatment/referral of phago-
cytic cell disorders, such as Chediak–Higashi syn-
drome, chronic granulomatous disease, leukocyte
adhesion defects, and a variety of congenital and
acquired neutropenias.
C. Technical Skills and Knowledge About
Technical ProceduresdObjectives
1. Performance and interpretation of skin prick, intrader-
mal, patch tests, and delayed hypersensitivity tests.
2. Performance of diagnostic testing for suspected drug,
biological, or vaccine allergy.
3. Safe preparation and administration of immunotherapy
vaccines.
4. Performance of allergen provocation tests, such as
nasal, conjunctival, bronchial, and oral challenges,
and food and medication challenges.
5. Performance of patch testing for contact dermatitis.
6. Performance or knowledge of rhinoscopy and laryn-
goscopy, nasal endoscopy, acoustic rhinometry, and
rhinomanometry.
7. Performance of basic lung function testing, including
spirometry and bronchial provocation tests (methacho-
line or histamine or mannitol challenges, measurement
of ﬂow-volume loops and pulse oximetry, and pre- and
postbronchodilator testing).
8. Knowledge of how and when to measure exhaled nitric
oxide, and how and when to perform whole-body
plethysmography and impulse oscillometry.
9. Knowledge of how and when to use various tests to
measure airway inﬂammation and/or constriction,
including induced sputum and/or bronchial and bron-
choalveolar lavage.
10. Assessment of environmental hazards in occupational
allergy.
11. Management of exclusion diets and provocation diets.
12. Knowledge of and ability to interpret measurements of
immune function, including serum immunoglobulin
levels, IgG subclass levels, pre- and postimmunization
antibody titers, isohemagglutinin titers, and other
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ancillary tests for use in the differential diagnosis of
congenital or acquired humoral immunodeﬁciency.
13. Measurement and interpretation of laboratory tests to
diagnose hereditary angioedema and complement
deﬁciencies.
14. Measurement of phagocytic and chemotactic function.
D. Attitudes
1. Ability to work with colleagues in other disciplines.
2. Appreciation of the scope and limitations of allergy
testing.
3. Appreciation of the limitations and problems created by
the so-called complementary medicine or alternative
allergy practices.
4. Understanding of the role of patient support groups and
ability and willingness to work with patient support
organizations.
5. Appreciation of all the issues relating to patient conﬁden-
tiality and the ethical standards expected of all physicians.
6. Understanding of the research protocols, the ethics of
experimental design, data analysis, biostatistics, good clin-
ical practice, good laboratory practice, and a willingness
to become involved in either clinical or basic translational
research.
7. Knowledge of the country-speciﬁc legal framework for
reporting of occupational diseases and assisting patients
in obtaining compensation for occupational diseases.
8. An ability to be a clinical decision maker, communicator,
collaborator, manager, health care advocate, and scholar.
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